Recent Quarter Total Invested
$2.07 B
Recent Quarter Institutional Ownership Percentage
111.04%
Total Invested of Last Quarter
$1.82 B
Ownership Percentage of Last Quarter
113.17%
Mirum Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 6.57 M | $256.25 M | 1.15% | 13.75% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 4.48 M | $174.74 M | -10.19% | 9.38% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 3.45 M | $134.37 M | -4.69% | 7.21% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 3.37 M | $131.36 M | 100.00% | 7.05% |
| BVF INC/IL | 11/14/2024 | 3.08 M | $119.96 M | -29.61% | 6.44% |
| STATE STREET CORP | 11/14/2024 | 1.79 M | $69.96 M | 19.88% | 3.75% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 1.58 M | $61.64 M | -10.81% | 3.31% |
| NOVO HOLDINGS A/S | 10/24/2024 | 1.50 M | $58.50 M | 0.00% | 3.14% |
| CITADEL ADVISORS LLC | 11/14/2024 | 1.39 M | $54.26 M | -12.25% | 2.91% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.29 M | $50.20 M | 0.00% | 2.69% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 1.28 M | $50.08 M | 7.08% | 2.69% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 936,197 | $36.52 M | 3.20% | 1.96% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 895,690 | $34.93 M | 2.35% | 1.87% |
| CLEARBRIDGE INVESTMENTS, LLC | 11/12/2024 | 889,100 | $34.67 M | 27.03% | 1.86% |
| LORD, ABBETT & CO. LLC | 11/14/2024 | 741,368 | $28.91 M | 100.00% | 1.55% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 731,104 | $28.51 M | 0.00% | 1.53% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 675,000 | $26.33 M | -8.91% | 1.41% |
| FIRST TURN MANAGEMENT, LLC | 11/07/2024 | 647,611 | $25.26 M | -7.93% | 1.36% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 637,967 | $24.88 M | -15.95% | 1.34% |
| MORGAN STANLEY | 11/14/2024 | 625,916 | $24.41 M | 15.69% | 1.31% |
| FRANKLIN RESOURCES INC | 11/12/2024 | 592,656 | $23.57 M | -37.06% | 1.24% |
| BOONE CAPITAL MANAGEMENT LLC | 11/14/2024 | 543,843 | $21.21 M | 3.85% | 1.14% |
| CANDRIAM S.C.A. | 11/13/2024 | 508,475 | $19.83 M | 0.00% | 1.06% |
| LOOMIS SAYLES & CO L P | 11/13/2024 | 499,316 | $19.47 M | 100.00% | 1.05% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 492,723 | $19.22 M | 0.03% | 1.03% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 492,409 | $19.20 M | 20.95% | 1.03% |
| CADIAN CAPITAL MANAGEMENT, LP | 11/14/2024 | 475,714 | $18.55 M | -61.48% | 1.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 466,209 | $18.18 M | 40.38% | 0.98% |
| PROSIGHT MANAGEMENT, LP | 11/14/2024 | 465,825 | $18.17 M | 47.97% | 0.97% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 455,564 | $17.77 M | 71.62% | 0.95% |
| AXA S.A. | 11/14/2024 | 426,068 | $16.62 M | 0.02% | 0.89% |
| WOODLINE PARTNERS LP | 11/14/2024 | 331,005 | $12.91 M | 62.48% | 0.69% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 328,161 | $12.80 M | 5.51% | 0.69% |
| PENN CAPITAL MANAGEMENT COMPANY, LLC | 11/14/2024 | 309,244 | $12.09 M | 28.24% | 0.65% |
| INVESCO LTD. | 11/12/2024 | 284,532 | $11.10 M | 0.17% | 0.60% |
| 11/14/2024 | 260,000 | $10.14 B | 100.00% | 0.54% | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 256,779 | $10.01 M | 100.00% | 0.54% |
| BARCLAYS PLC | 11/19/2024 | 245,918 | $9.59 M | 4.60% | 0.51% |
| RICE HALL JAMES & ASSOCIATES, LLC | 10/28/2024 | 242,711 | $9.47 M | 5.65% | 0.51% |
| NEW YORK STATE COMMON RETIREMENT FUND | 10/28/2024 | 228,351 | $8.91 M | 20.11% | 0.48% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 227,473 | $8.87 M | 39.09% | 0.48% |
| ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 220,394 | $8.60 M | -1.00% | 0.46% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 205,500 | $8.01 M | 14.23% | 0.43% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 190,476 | $7.43 M | 0.00% | 0.40% |
| ARDSLEY ADVISORY PARTNERS LP | 11/14/2024 | 190,000 | $7.41 M | 5.56% | 0.40% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 183,344 | $7.15 M | 1,097.78% | 0.38% |
| NEXT CENTURY GROWTH INVESTORS LLC | 11/14/2024 | 164,371 | $6.41 M | 100.00% | 0.34% |
| FIRST TRUST ADVISORS LP | 11/13/2024 | 146,411 | $5.71 M | 434.60% | 0.31% |
| NICHOLAS INVESTMENT PARTNERS, LP | 11/12/2024 | 144,479 | $5.63 M | 100.00% | 0.30% |
| HEALTHINVEST PARTNERS AB | 11/12/2024 | 138,321 | $5.39 M | 83.94% | 0.29% |
Mirum Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of MIRM shares?
During the previous two years, 199 institutional investors and hedge funds held shares of Mirum Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Frazier Life Sciences Management, L.P.: 6.57 M
JANUS HENDERSON GROUP PLC: 4.48 M
EVENTIDE ASSET MANAGEMENT, LLC: 3.45 M
BlackRock Funding, Inc. /DE: 3.37 M
BVF INC/IL: 3.08 M
STATE STREET CORP: 1.79 M
-
What percentage of Mirum Pharmaceuticals, Inc. stock is owned by institutional investors?
111.04% of Mirum Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at MIRM ?
Institutional investors have bought a total of 54.16 M shares in the last 24 months. This purchase volume represents approximately $2.42 B in transactions.